BackgroundThe risk and protective factors of amnestic mild cognitive impairment (aMCI) and its prevalence as well as incidence among old adult in Chinese community are still unclear. MethodsWe carried
This study evaluated the safety and efficacy of daily subcutaneous Copper Histidine (CuHis) injections given over three years to impact the neurodevelopmental outcomes in infants with Menkes disease.
